【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Antibiotics – Market size and forecast 2018-2023
• Analgesics – Market size and forecast 2018-2023
• Other therapeutics – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Amryt Pharma
• Fresenius
• Johnson & Johnson
• Novartis
• Pfizer
PART 13: APPENDIX
• Research methodology
• List of abbreviations
Exhibit 01: Years in consideration
Exhibit 02: Global rare diseases therapeutics market
Exhibit 03: Segments of global rare diseases therapeutics market
Exhibit 04: Market characteristics
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Product – Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Antibiotics – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Antibiotics – Year-over-year growth 2019-2023 (%)
Exhibit 21: Analgesics – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Analgesics – Year-over-year growth 2019-2023 (%)
Exhibit 23: Other therapeutics – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Other therapeutics – Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America – Year-over-year growth 2019-2023 (%)
Exhibit 31: Top 3 countries in North America
Exhibit 32: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 34: Top 3 countries in Europe
Exhibit 35: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 37: Top 3 countries in Asia
Exhibit 38: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 39: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 40: Top 3 countries in ROW
Exhibit 41: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Decision framework
Exhibit 44: Recent therapeutics that have received orphan drug designation from the US FDA
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Early phase developmental therapeutics for the treatment of epidermolysis bullosa
Exhibit 47: Vendor landscape
Exhibit 48: Landscape disruption
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: Amryt Pharma – Vendor overview
Exhibit 53: Amryt Pharma – Business segments
Exhibit 54: Amryt Pharma – Organizational developments
Exhibit 55: Amryt Pharma – Geographic focus
Exhibit 56: Amryt Pharma – Segment focus
Exhibit 57: Amryt Pharma – Key offerings
Exhibit 58: Amryt Pharma – Key customers
Exhibit 59: Fresenius – Vendor overview
Exhibit 60: Fresenius – Business segments
Exhibit 61: Fresenius – Organizational developments
Exhibit 62: Fresenius – Geographic focus
Exhibit 63: Fresenius – Segment focus
Exhibit 64: Fresenius – Key offerings
Exhibit 65: Fresenius – Key customers
Exhibit 66: Johnson & Johnson – Vendor overview
Exhibit 67: Johnson & Johnson – Business segments
Exhibit 68: Johnson & Johnson – Organizational developments
Exhibit 69: Johnson & Johnson – Geographic focus
Exhibit 70: Johnson & Johnson – Segment focus
Exhibit 71: Johnson & Johnson – Key offerings
Exhibit 72: Johnson & Johnson – Key customers
Exhibit 73: Novartis – Vendor overview
Exhibit 74: Novartis – Business segments
Exhibit 75: Novartis – Organizational developments
Exhibit 76: Novartis – Geographic focus
Exhibit 77: Novartis – Segment focus
Exhibit 78: Novartis – Key offerings
Exhibit 79: Novartis – Key customers
Exhibit 80: Pfizer – Vendor overview
Exhibit 81: Pfizer – Business segments
Exhibit 82: Pfizer – Organizational developments
Exhibit 83: Pfizer – Geographic focus
Exhibit 84: Pfizer – Segment focus
Exhibit 85: Pfizer – Key offerings
Exhibit 86: Pfizer – Key customers
Exhibit 87: Validation techniques employed for market sizing
Exhibit 88: List of abbreviations
【レポート販売概要】
■ タイトル：表皮水疱症治療薬の世界市場2019-2023■ 英文：Global Epidermolysis Bullosa Therapeutics Market 2019-2023
■ 発行日：2019年1月17日
■ 調査会社：Technavio
■ 商品コード：IRTNTR30680
■ 調査対象地域：グローバル、アジア、北米、ヨーロッパ（EMEA）
- ポリオールの世界市場：ポリエーテルポリオール、ポリエステルポリオールAbout Polyols Polyols are one of the main ingredients of polyurethane foams. Polyol is an alcohol that contains multiple hydroxyl groups. Polyols are segmented into polyether and polyester polyols. Polyether polyols are manufactured by the propoxylation of a polyhydric alcohol in the presence of a catalyst. Bio-based polyols are expected to boost the global polyols market, as global companies are …
- ポリイミドフィルム（PIフィルム）の世界市場予測（～2022年）“The global polyimide films market is projected to grow at a CAGR of 10.0% from 2017 to 2022, in terms of value” The global polyimide films market is estimated to be valued at USD 1.52 billion in 2017 and is projected to reach USD 2.45 billion by 2022, at a CAGR of 10.0% from 2017 to 2022. Increased demand from the consumer electronics industry, growing automotive industry, and superior thermal & …
- Consumers Energy Company：石油・ガスバリューチェーン分析レポート2013Consumers Energy Company Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Consumers Energy Company" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Consumers Energy Company”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The …
- コラーゲンの世界市場：原料別（ウシ、ブタ）、製品別（ゼラチン、ネイティブ、加水分解）、アプリケーション別（食品・飲料、ヘルスケア）、セグメント予測The global collagen market size is projected to reach USD 6.63 billion by 2025, according to a new report by Grand View Research, Inc., registering a 6.5% CAGR during the forecast period. The market is expected to be driven by the product’s growing application scope in the food and beverage as well as healthcare and pharmaceutical industries. In addition, the market is expected to benefit from inc …
- イムノアッセイの世界市場予測：試薬、キット、分析器、ソフトウェア、サービスThe global immunoassay market consists of various products that are used by hospitals, clinical laboratories, blood banks, research and academic laboratories, and pharmaceutical companies. The market is expected to reach USD 25.45 Billion by 2021 from USD 17.16 Billion in 2016 at a CAGR of 8.2%. This market is segmented based on product & service, technology, application, end user, and region. The …
- アトピー性皮膚炎治療薬の世界市場予測および分析（～2024）PharmaPoint: Atopic Dermatitis - Global Drug Forecast and Market Analysis to 2024 Summary Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for others to follow suit. By the mid-to-late term of GlobalData’s 201 …
- パブリック及びプライベート・クラウド・ストレージの世界市場About Public and Private Cloud Storage Cloud storage is a data storage model where the data is stored in remote locations in data centers. Cloud storage solution providers either sell or lease their storage infrastructure to organizations to store and access their data in space provided over the network or internet. Under the private cloud model, the organization is provided with dedicated space o …
- 世界の大型トラック市場動向This latest just-auto report edition offers a global review of the heavy trucks sector, its manufacturers, top markets, technologies and market forecasts. This global market study offers: Heavy trucks market size estimates Latest technologies and trends Manufacturer production and sales volumes and forecasts Profiles of the major players including their strategies and prospects Market size forecas …
- 銀採鉱の世界市場（～2020）Timetric estimates global silver production at 936 million ounces in 2014, up by 2.7% from 2013. Global reserves as of January 2015 were 529,900 tonnes (t), with four countries accounting for 65.3% of the total: Peru (98,900t) Australia (85,000t), Poland (85,000t) and Chile (77,000t). The remainder is found China (43,000t), Mexico (37,000t), the US (25,000t), Bolivia (22,000t) and Canada (7,000t).
- 窒素発生器の世界市場：種類別（PSA窒素発生器、膜窒素発生器、低温窒素発生器）、最終用途産業別（食品および飲料、輸送、医療および医薬品、電気および電子機器、化学薬品）The global nitrogen generators market was valued at $11,776.1 million in 2018, and is projected to reach $17,435.5 million in 2026, growing at a CAGR of 4.9%. Nitrogen generator is a type of industrial on-site gas generation systems. This system serves as an ideal method to supply nitrogen across many manufacturing industries such as metal, semiconductor, chemicals, and others. The factors that dr …
- 世界の溶接ロボット市場：アーク溶接/スポット溶接/レーザー溶接ロボットAbout Welding Robot Industrial robots are programmable, automatically operated machines (or robot systems) that have been developed to replace the human effort in industries. Industrial robots are programmed to automate and control manufacturing processes. They are used in applications such as welding, painting, assembly, product inspection, testing, and packaging. Industrial robots used specifica …
- 海中ポンプの世界市場：らせん軸ポンプ、水中電動ポンプ、渦巻ポンプAbout Subsea Pumps Subsea pumps are used in the Oil and Gas industry to enhance oil recovery and to maintain the flow of fluids in subsea production systems. These pumps accelerate the production process and improve the flow assurance in subsea oil and gas reservoirs. With the development of subsea infrastructure and increasing number of subsea projects, the adoption of subsea pumps is expected to …
- 世界の電子部品用接着剤市場（～2019）The electronic adhesives market was estimated around $3.0 billion in 2013, with the highest share of more than 60% held by Asia-Pacific and RoW together. The global market is projected to grow at a CAGR of 10.1% from 2014 to 2019 to reach $5.5 billion by 2019. The highest investment is projected to be in the Asia-Pacific region due to the growing application markets, especially in China. The elect …
- 世界の農薬市場におけるM&A動向：作物保護用化学品、除草剤、殺菌剤、殺虫剤The global agrochemicals market in the year 2013 stood at USD 41.12 Billion, marking a massive 43% growth compared to USD 28.78 Billion. Increased participation of private players and their rigorous effort in improving products and expanding worldwide has supported enormous growth in the agrochemicals market. Mergers & acquisitions have resulted in the consolidation of the agrochemicals market, an …
- 動脈硬化：治療薬の治験動向（2014年下半期）Arteriosclerosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Arteriosclerosis Global Clinical Trials Review, H2, 2014" provides data on the Arteriosclerosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arteriosclerosis. It includes an overview of the trial numbers and their recruitment statu …
